Browsing by Author "Moreno, Mireia"

Sort by: Order: Results:

  • Martínez Bosch, Neus; Barranco Priego, Luis Eugenio; Orozco, Carlos Alberto; Moreno, Mireia; Visa Turmo, Laura; Iglesias Coma, Mar; Oldfield, Lucy; Neoptolemos, John P.; Greenhalf, William; Earl, Julie; Carrato, Alfredo; Costello, Eithne; Navarro Medrano, Pilar (Impact Journal, 2018)
    Pancreatic ductal adenocarcinoma (PDA) is the most frequent type of pancreatic cancer and one of the deadliest diseases overall. New biomarkers are urgently needed to allow early diagnosis, one of the only factors that ...
  • Miró, Laura; López, Júlia; Guerrero, Pedro E.; Martínez Bosch, Neus; Manero Rupérez, Noemí; Moreno, Mireia; Ortiz, María Rosa; Llop Escorihuela, Esther; Navarro Medrano, Pilar; Peracaula, Rosa (MDPI, 2022)
    Hypersialylation is a feature of pancreatic ductal adenocarcinoma (PDA) and it has been related to tumor malignancy and immune suppression. In this work, we have evaluated the potential of the sialyltransferase inhibitor, ...
  • Martínez Bosch, Neus; Cristóbal, Helena; Iglesias Coma, Mar; Gironella, Meritxell; Barranco Priego, Luis Eugenio; Visa Turmo, Laura; Calafato, Domenico; Jiménez-Parrado, Silvia; Earl, Julie; Carrato, Alfredo; Manero Rupérez, Noemí; Moreno, Mireia; Morales, Albert; Guerra, Carmen; Navarro Medrano, Pilar; García de Frutos, Pablo (Elsevier, 2022)
    Background: Early diagnosis is crucial for patients with pancreatic ductal adenocarcinoma (PDAC). The AXL receptor tyrosine kinase is proteolytically processed releasing a soluble form (sAXL) into the blood stream. Here ...
  • Llop, Maria; Moreno, Mireia; Navarro-Compán, Victoria; Juanola, Xavier; Miguel, Eugenio de; Almodóvar, Raquel; Cuende Quintana, Eduardo; Sanz Sanz, Jesús; Beltrán, Emma; Ruiz Montesinos, M. Dolores; Calvet, Joan; Berenguer-Llergo, Antonio; Gratacós, Jordi; Regisponserbio group (BioMed Central, 2022)
    Background: To evaluate the influence of the disease activity on radiographic progression in axial spondyloarthritis (axSpA) patients treated with TNF inhibitors (TNFi). Methods: The study included 101 axSpA patients from ...
  • Orozco, Carlos Alberto; Martínez Bosch, Neus; Enrique Guerrero, Pedro; Vinaixa Forner, Judith, 1991-; Dalotto-Moreno, Tomás; Iglesias García, Mar; Moreno, Mireia; Djurec, Magdolna; Poirier, Françoise; Gabius, Hans J.; Fernández-Zapico, Martin E.; Hwang, Rosa F.; Guerra, Carmen; Rabinovich, Gabriel A.; Navarro Medrano, Pilar (National Academy of Sciences, 2018)
    Pancreatic ductal adenocarcinoma (PDA) remains one of the most lethal tumor types, with extremely low survival rates due to late diagnosis and resistance to standard therapies. A more comprehensive understanding of the ...
  • Martínez Bosch, Neus; Enrique Guerrero, Pedro; Moreno, Mireia; José Segarra-Martínez, Anabel; Iglesias García, Mar; Munné-Collado, Jessica; Anta Rodríguez, Héctor, 1988-; Gibert, Joan; Orozco, Carlos Alberto; Vinaixa Forner, Judith, 1991-; Fillat i Fonts, Cristina; Viñals, Francesc; Navarro Medrano, Pilar (Impact Journals, 2016)
    Current treatments for pancreatic ductal adenocarcinoma (PDA) are ineffective, making this the 4th leading cause of cancer deaths. Sunitinib is a broad-spectrum inhibitor of tyrosine kinase receptors mostly known for its ...
  • Moreno, Mireia; Lisbona Pérez, María Pilar; Gallardo Hernández, Fernando; Deza Vargas, Luis Gustavo; Ferran Farrés, Marta; Pontes, Caridad; Luelmo, Jesús; Maymó Guarch, Joan; Gratacós, Jordi (Society for Publication of Acta Dermato-Venereologica, 2019)
    This cross-sectional study evaluated the usefulness of an ultrasound technique in assessment of nail changes in 35 patients with psoriatic onychopathy and 25 with nail dystrophy secondary to onychomycosis. All patients ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking